Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayden

Showing results (681-690 of 1,032) with videos related to

Pageof 104
Sort By:
Circulation|May 29, 2003
Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoproteinRadjesh J Bisoendial, G Kees Hovingh, Johannes H M Levels, et al.
Human Molecular Genetics|June 19, 2008
Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's diseaseChuan-En Wang, Suzanne Tydlacka, Adam L Orr, et al.
Genetics in Medicine Open|December 13, 2024
Ascertainment of uninterrupted CAG repeat length and disease-modifying variants in fragment-based genetic testing for Huntington DiseaseHailey Findlay Black, Chris Kay, Jessica Dawson, et al.
Journal of Neurochemistry|July 5, 2005
Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington diseaseJohn T Pinto, Jeremy M Van Raamsdonk, Blair R Leavitt, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in childrenK Pussegoda, C J Ross, H Visscher, et al.
British Journal of Haematology|December 11, 2019
Validation of a simplified international prognostic score (IPS-3) in patients with advanced-stage classic Hodgkin lymphomaAnna R Hayden, Derrick G Lee, Diego Villa, et al.
Haematologica|October 2, 2025
Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapyJiayu Yang, Anna R Hayden, Diego Villa, et al.
Molecular Therapy. Nucleic Acids|October 6, 2025
Molecular and imaging biomarker responses to brain mutant HTT lowering in a mouse model of Huntington diseaseNicholas S Caron, Jianjia Fan, Da Ma, et al.
Genome Medicine|June 2, 2017
A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosisColin J Ross, Fadi Towfic, Jyoti Shankar, et al.
Archives of Neurology|December 17, 2003
Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosisCollette K Hand, Rebecca S Devon, Francois Gros-Louis, et al.
Pageof 104

Showing results (681-690 of 1,032) with videos related to

Sort By:
Pageof 104
Circulation|May 29, 2003
Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoproteinRadjesh J Bisoendial, G Kees Hovingh, Johannes H M Levels, et al.
Human Molecular Genetics|June 19, 2008
Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's diseaseChuan-En Wang, Suzanne Tydlacka, Adam L Orr, et al.
Genetics in Medicine Open|December 13, 2024
Ascertainment of uninterrupted CAG repeat length and disease-modifying variants in fragment-based genetic testing for Huntington DiseaseHailey Findlay Black, Chris Kay, Jessica Dawson, et al.
Journal of Neurochemistry|July 5, 2005
Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington diseaseJohn T Pinto, Jeremy M Van Raamsdonk, Blair R Leavitt, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in childrenK Pussegoda, C J Ross, H Visscher, et al.
British Journal of Haematology|December 11, 2019
Validation of a simplified international prognostic score (IPS-3) in patients with advanced-stage classic Hodgkin lymphomaAnna R Hayden, Derrick G Lee, Diego Villa, et al.
Haematologica|October 2, 2025
Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapyJiayu Yang, Anna R Hayden, Diego Villa, et al.
Molecular Therapy. Nucleic Acids|October 6, 2025
Molecular and imaging biomarker responses to brain mutant HTT lowering in a mouse model of Huntington diseaseNicholas S Caron, Jianjia Fan, Da Ma, et al.
Genome Medicine|June 2, 2017
A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosisColin J Ross, Fadi Towfic, Jyoti Shankar, et al.
Archives of Neurology|December 17, 2003
Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosisCollette K Hand, Rebecca S Devon, Francois Gros-Louis, et al.
Pageof 104